DarioHealth Corp.
DRIO
$0.6301
$0.00811.30%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.42M | 6.26M | 5.76M | 3.62M | 3.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.42M | 6.26M | 5.76M | 3.62M | 3.52M |
| Cost of Revenue | 2.20M | 2.27M | 2.16M | 2.38M | 1.80M |
| Gross Profit | 5.22M | 3.99M | 3.60M | 1.24M | 1.72M |
| SG&A Expenses | 10.46M | 12.14M | 13.65M | 10.02M | 10.49M |
| Depreciation & Amortization | 1.34M | 1.23M | 1.16M | 1.11M | 1.11M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.45M | 22.45M | 23.61M | 17.70M | 19.06M |
| Operating Income | -12.03M | -16.19M | -17.86M | -14.09M | -15.55M |
| Income Before Tax | -12.34M | -13.61M | -9.17M | -14.22M | -15.73M |
| Income Tax Expenses | -13.00K | -- | -1.99M | 64.00K | -- |
| Earnings from Continuing Operations | -12.33M | -13.61M | -7.18M | -14.29M | -15.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.33M | -13.61M | -7.18M | -14.29M | -15.73M |
| EBIT | -12.03M | -16.19M | -17.86M | -14.09M | -15.55M |
| EBITDA | -10.32M | -14.35M | -16.53M | -12.77M | -14.31M |
| EPS Basic | -0.25 | -0.08 | -0.20 | -0.42 | -0.49 |
| Normalized Basic EPS | -0.19 | -0.21 | -0.17 | -0.30 | -0.34 |
| EPS Diluted | -0.25 | -0.08 | -0.20 | -0.42 | -0.49 |
| Normalized Diluted EPS | -0.19 | -0.21 | -0.17 | -0.30 | -0.34 |
| Average Basic Shares Outstanding | 40.42M | 39.83M | 34.44M | 28.90M | 28.82M |
| Average Diluted Shares Outstanding | 40.42M | 39.83M | 34.44M | 28.90M | 28.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
